1 week ago

Active Pharmaceutical Ingredients (API) Market Analysis by Growth Rate and Trends with Forecast to 2025

molecules. The R&D

molecules. The R&D investment of the company are no longer valuable after patent expiration. Thus, the API outsourcing trend in rising. Synthesis Type Insights Based on synthesis type, the market is categorized into synthetic and biotech. Various methods are adopted by the manufacturing companies depending up on the complexity of the molecule required. Synthetic drugs are manufactured on the basis of organic chemistry in contrast to biotechnology based drugs, which are produced by utilizing molecular techniques. Further classification of biotech segment is recombinant proteins, monoclonal antibodies and vaccines. In 2015, synthetic segment held the largest share. The key factors for the biotech APIs segment growth are large R&D investment for new biosimilars, increasing demand for protein-based medicines, and rising focus of key manufacturers toward biological drugs. Manufacturer Type Insights Based on the type of manufacturer, it is categorized into outsourced or merchant or in-house or captive APIs. According to market estimates, in 2015, in-house APIs was the largest segment and outsourced APIs are anticipated to be the fastest growing market. All pharmaceutical companies does not have separate unit for the formulation of API. This has led to rise in the outsourcing of the molecules from the production sites. The need of investment in expensive production processes is eliminated by the outsourcing. Request Sample Copy of this Market Research @ Type Insights Based on the type, APIs are classified into innovative and generics. Branded products come under innovative type, whereas the generic drugs are the ones, which are available OTC (over the counter). Owing of high rate of prescription, high drug development initiatives, and high price, the innovative APIs segment dominated in 2015. Generic segment is anticipated to be fastest-growing type, due to expirations of patents of various blockbuster drugs. Patent expirations of branded drugs have very serious negative impacts on the drug producers, as the companies face the tremendous loss after expiration. Hence the drug manufacturers prefer more generic drugs than the branded ones. Application Insights

Cancer, neurological disorders & CNS, endocrinal disorders and cardiovascular diseases are some of the major applications of the API. In 2015, CVD (cardiovascular diseases) dominated the market owing to its high rate of prevalence and high product availability. CVD has been reported as the major cause of death in the U.S since many years. In addition, oncology is expected to be the fastest-growing segment and is estimated to witness the CAGR of 7% owing to high number of products waiting approval. Moreover, increasing prevalence of cancer worldwide is anticipated to further boost market. See More Reports of this Category by Million Insights @: Regional Insights In 2015, API market was dominated by the North America and is anticipated to retain its position in upcoming years owing to encouraging government initiatives for generic drug usage, rising R&D expenditure, and technological advancements in the drug manufacturing practices. Asia Pacific is anticipated to be the region with fastest growth owing to the increasing availability of cheap and affordable labour. Hence, key major companies are setting up their API production plants in developing countries of Asia Pacific such as China and India. Competitive Insights One of the key manufacturers of the API (Active pharmaceutical ingredients) is Teva Pharmaceuticals Ltd. Some of the additional key players in this industry includes Boehringer Ingelheim GmbH, AbbVie, Inc., Merck & Co., Inc. and Cipla, Inc., New molecule launches, collaborations, acquisitions, and regional expansions are some strategic initiatives taken by these Key players to retain their position.

Active Pharmaceutical Ingredient (API) Market by Synthesis & Type
Plant Derived Cleaning Ingredients Market Volume Forecast and Value Chain Analysis 2016-2026
API Audits & Inspections - Active Pharmaceutical Ingredients ...
Prebiotic Ingredient Market size, share and Key Trends 2015-2025 by FMI
Paper Coating Materials Market 2015-2025 Shares, Trend and Growth Report
Malt Ingredients Market Volume Forecast and Value Chain Analysis 2015-2025 by Future Market Insights
Internet Security Market Analysis, Segments, Growth and Value Chain 2015-2025
Bakery Ingredients Market Growth, Trends and Value Chain 2015-2025 by FMI
Global Active pharmaceutical ingredient Market is Expected to Cross USD 213.84 Billion in 2021
Protein Ingredient Market size, share and Key Trends 2015-2025 by Future Market Insights
Sauces, Dressings and Condiments Global Market: Insights, Market Size, Share, Growth, Trends Analysis and Forecast to 2021
Research Report and Overview on Protein Hydrolysate Ingredient Market, 2015 – 2025
FMI: Electric Water Heater Market Segments, Opportunity, Growth and Forecast By End-use Industry 2015-2025
Tara Gum Market: 10-Year Market Forecast and Trends Analysis Research Report
Exploratory Study on Active Pharmaceutical Ingredient ... - Unido
Confectionery Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecasts to 2022
Cosmetic Ingredients Market Volume Analysis, Segments, Value Share and Key Trends 2015-2025
Direct Drive Wind Turbine Market Volume Analysis, size, share and Key Trends 2015-2025 by Future Market Insights
Animal Feed Additives Market: Global Industry Analysis and Forecast Till 2025 by FMI
Small Cell Market Trends, Share, Revenue, Analysis 2017-2025
FMI: Water Softening Systems Market Volume Analysis, Segments, Value Share and Key Trends 2015-2025
Optical Transreciever Market with Current Trends Analysis,2015-2025
Connected TV’s Market Segments and Forecast By End-use Industry 2015-2025
FMI: Feed Probiotics Market Revenue, Opportunity, Forecast and Value Chain 2015-2025
Stem Cell Market | Global Industry Trends, Statistics & Future Prospects Forecast 2017-2025